Share:
  • Title:Results of Pembrolizumab in High-Risk Stage III Melanoma
  • Duration: 2:35
  • Views: 297
  • Uploaded: 6 years ago

Similar Songs

3-Year Update Shows Continued Efficacy of Pembrolizumab for Melanoma▶️ 1:23
3-year Update Shows Continued Efficacy Of Pembrolizumab For Melanoma 146 views • 4 years ago
Results from KEYNOTE-716: adjuvant therapy with pembrolizumab in high-risk stage II melanoma▶️ 1:36
Results From Keynote-716: Adjuvant Therapy With Pembrolizumab In High-risk Stage Ii Melanoma 123 views • 2 years ago
KEYNOTE-716: safety profile and results of pembrolizumab for melanoma▶️ 1:08
Keynote-716: Safety Profile And Results Of Pembrolizumab For Melanoma 117 views • 3 years ago
ASCO: Pembrolizumab for Adjuvant Treatment of High-Risk Stage III Melanoma▶️ 10:47
Asco: Pembrolizumab For Adjuvant Treatment Of High-risk Stage Iii Melanoma 60 views • 4 years ago
#ESMO21 Highlights on pembrolizumab in fully resected high-risk stage II melanoma: KEYNOTE-716 study▶️ 2:19
#esmo21 Highlights On Pembrolizumab In Fully Resected High-risk Stage Ii Melanoma: Keynote-716 Study 1.6K views • 3 years ago
Dr. Eggermont on Responses to Adjuvant Pembrolizumab in Stage III Melanoma Subtypes▶️ 1:34
Dr. Eggermont On Responses To Adjuvant Pembrolizumab In Stage Iii Melanoma Subtypes 162 views • 4 years ago
KEYNOTE-716: pembrolizumab for patients with high-risk stage II melanoma▶️ 3:39
Keynote-716: Pembrolizumab For Patients With High-risk Stage Ii Melanoma 416 views • 3 years ago
Melanoma | 2022 OneOncology Conference▶️ 25:50
Melanoma | 2022 Oneoncology Conference 347 views • 1 year ago
NeoPeLe: neoadjuvant pembrolizumab and lenvatinib in resectable stage III melanoma▶️ 1:20
Neopele: Neoadjuvant Pembrolizumab And Lenvatinib In Resectable Stage Iii Melanoma 290 views • 2 years ago
KEYNOTE-716: adjuvant therapy with pembrolizumab for patients with high-risk stage II melanoma▶️ 5:54
Keynote-716: Adjuvant Therapy With Pembrolizumab For Patients With High-risk Stage Ii Melanoma 383 views • 3 years ago
KEYNOTE-716: long-term efficacy and safety of pembrolizumab in resected melanoma▶️ 1:43
Keynote-716: Long-term Efficacy And Safety Of Pembrolizumab In Resected Melanoma 53 views • 2 days ago
KEYNOTE-716: adjuvant pembrolizumab for high-risk melanoma▶️ 0:43
Keynote-716: Adjuvant Pembrolizumab For High-risk Melanoma 111 views • 3 years ago
Developments in the Management of Stage III Melanoma▶️ 3:40
Developments In The Management Of Stage Iii Melanoma 2.2K views • 5 years ago
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab▶️ 10:36
Results Of Keynote-054; Melanoma Patients Treated With Pembrolizumab 259 views • 6 years ago
Dr. Weber on Adjuvant Pembrolizumab in Melanoma▶️ 1:22
Dr. Weber On Adjuvant Pembrolizumab In Melanoma 415 views • 4 years ago
Results from the KEYNOTE-716: Pembrolizumab versus placebo after complete resection of high-risk...▶️ 3:46
Results From The Keynote-716: Pembrolizumab Versus Placebo After Complete Resection Of High-risk... 87 views • 3 years ago
Investigators Present Updated Results of the OpACIN Trial for Melanoma▶️ 1:12
Investigators Present Updated Results Of The Opacin Trial For Melanoma 80 views • 4 years ago
Dr. Weber on FDA Approval of Pembrolizumab for Stage III Melanoma▶️ 0:57
Dr. Weber On Fda Approval Of Pembrolizumab For Stage Iii Melanoma 148 views • 5 years ago
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber▶️ 3:40
Aacr 2023 Highlights On Advances In The Treatment Of Resected High-risk Melanoma With Jeffrey Weber 1K views • 1 year ago